Kiniksa Pharmaceuticals International, plc Operating Cash Flow
Kiniksa Pharmaceuticals International, plc (KNSA) reported Operating Cash Flow of $50.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $50.20M, a 124.87% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $53.89M, a 187.13% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $33.68M.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was $28.09M, a 443.54% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for fiscal 2025 was $137.99M, a 437.14% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for fiscal 2024 was $25.69M, a 93.14% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for fiscal 2023 was $13.30M, a 129.05% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc net cash provided by (used in) operating activities for fiscal 2022 was $5.81M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | $50.20M 10-Q · filed 2026-04-28 | $104.09M derived: sum of 2 quarters · filed 2026-04-28 | $137.77M derived: sum of 3 quarters · filed 2026-04-28 | $165.86M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $53.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $87.57M derived: sum of 2 quarters · filed 2026-02-24 | $115.66M derived: sum of 3 quarters · filed 2026-02-24 | $137.99M 10-K · filed 2026-02-24 |
| 2025-09-30 | $33.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $61.77M derived: sum of 2 quarters · filed 2025-10-28 | $84.09M 10-Q · filed 2025-10-28 | $102.86M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $28.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $50.41M 10-Q · filed 2025-07-29 | $69.18M derived: sum of 3 quarters · filed 2026-04-28 | $66.95M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $22.32M 10-Q · filed 2026-04-28 | $41.09M derived: sum of 2 quarters · filed 2026-04-28 | $38.86M derived: sum of 3 quarters · filed 2026-04-28 | $44.03M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $18.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $16.53M derived: sum of 2 quarters · filed 2026-02-24 | $21.70M derived: sum of 3 quarters · filed 2026-02-24 | $25.69M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.93M derived: sum of 2 quarters · filed 2025-10-28 | $6.92M 10-Q · filed 2025-10-28 | $11.24M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $9.15M 10-Q · filed 2025-07-29 | $13.48M derived: sum of 3 quarters · filed 2026-02-24 | $30.47M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $3.99M 10-Q · filed 2025-04-29 | $8.31M derived: sum of 2 quarters · filed 2026-02-24 | $25.30M derived: sum of 3 quarters · filed 2026-02-24 | $21.55M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $21.31M derived: sum of 2 quarters · filed 2026-02-24 | $17.57M derived: sum of 3 quarters · filed 2026-02-24 | $13.30M 10-K · filed 2026-02-24 |
| 2023-09-30 | $16.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $13.24M derived: sum of 2 quarters · filed 2024-10-29 | $8.98M 10-Q · filed 2024-10-29 | -$2.60M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | -$8.01M 10-Q · filed 2024-07-25 | -$19.59M derived: sum of 3 quarters · filed 2025-02-25 | $42.47M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$4.27M 10-Q · filed 2024-04-25 | -$15.84M derived: sum of 2 quarters · filed 2025-02-25 | $46.21M derived: sum of 3 quarters · filed 2025-02-25 | $38.39M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $50.48M derived: sum of 2 quarters · filed 2025-02-25 | $42.65M derived: sum of 3 quarters · filed 2025-02-25 | $5.81M 10-K · filed 2025-02-25 |
| 2022-09-30 | $62.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $54.23M derived: sum of 2 quarters · filed 2023-11-02 | $17.38M 10-Q · filed 2023-11-02 | -$1.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$7.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$44.67M 10-Q · filed 2023-08-01 | -$63.55M derived: sum of 3 quarters · filed 2024-02-28 | -$92.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$36.85M 10-Q · filed 2023-05-04 | -$55.73M derived: sum of 2 quarters · filed 2024-02-28 | -$84.24M derived: sum of 3 quarters · filed 2024-02-28 | -$123.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$18.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$47.39M derived: sum of 2 quarters · filed 2024-02-28 | -$86.18M derived: sum of 3 quarters · filed 2024-02-28 | -$126.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$28.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$67.29M derived: sum of 2 quarters · filed 2022-11-03 | -$107.41M 10-Q · filed 2022-11-03 | -$148.60M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$38.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$78.91M 10-Q · filed 2022-08-04 | -$120.10M derived: sum of 3 quarters · filed 2023-03-02 | -$154.42M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$40.12M 10-Q · filed 2022-05-05 | -$81.31M derived: sum of 2 quarters · filed 2023-03-02 | -$115.63M derived: sum of 3 quarters · filed 2023-03-02 | -$144.86M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$41.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$75.51M derived: sum of 2 quarters · filed 2023-03-02 | -$104.74M derived: sum of 3 quarters · filed 2023-03-02 | -$136.53M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$34.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$63.55M derived: sum of 2 quarters · filed 2021-11-04 | -$95.34M 10-Q · filed 2021-11-04 | -$119.51M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$29.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$61.02M 10-Q · filed 2021-08-05 | -$85.19M derived: sum of 3 quarters · filed 2022-02-24 | -$114.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$31.80M 10-Q · filed 2021-05-06 | -$55.97M derived: sum of 2 quarters · filed 2022-02-24 | -$85.23M derived: sum of 3 quarters · filed 2022-02-24 | -$126.91M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$24.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$53.44M derived: sum of 2 quarters · filed 2022-02-24 | -$95.11M derived: sum of 3 quarters · filed 2022-02-24 | -$158.37M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$29.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$70.94M derived: sum of 2 quarters · filed 2020-11-05 | -$134.20M 10-Q · filed 2020-11-05 | -$161.84M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$41.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$104.93M 10-Q · filed 2020-08-04 | -$132.57M derived: sum of 3 quarters · filed 2021-02-25 | -$153.06M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$63.26M 10-Q · filed 2020-05-04 | -$90.89M derived: sum of 2 quarters · filed 2021-02-25 | -$111.38M derived: sum of 3 quarters · filed 2021-02-25 | -$129.30M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$27.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$48.12M derived: sum of 2 quarters · filed 2021-02-25 | -$66.04M derived: sum of 3 quarters · filed 2021-02-25 | -$81.01M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$20.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$38.40M derived: sum of 2 quarters · filed 2019-11-05 | -$53.37M 10-Q · filed 2019-11-05 | -$76.75M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | -$17.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$32.89M 10-Q · filed 2019-08-13 | -$56.27M derived: sum of 3 quarters · filed 2019-08-13 | -$67.21M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | -$14.97M 10-Q · filed 2019-05-07 | -$38.35M derived: sum of 2 quarters · filed 2019-05-07 | -$49.29M derived: sum of 3 quarters · filed 2019-05-07 | |
| 2017-12-31 | -$23.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$34.32M derived: sum of 2 quarters · filed 2019-03-12 | -$50.22M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$26.84M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$15.90M 10-Q · filed 2018-08-06 |